title: Release rates of indomethacin from commercial witepsol suppositories and the bioavailabilities in rabbits and pigs.
authors.forename: N
authors.initials: N
authors.lastname: Aoyagi
authors.forename: N
authors.initials: N
authors.lastname: Kaniwa
authors.forename: Y
authors.initials: Y
authors.lastname: Takeda
authors.forename: M
authors.initials: M
authors.lastname: Uchiyama
authors.forename: F
authors.initials: F
authors.lastname: Takamura
authors.forename: Y
authors.initials: Y
authors.lastname: Kido
mesh_terms: D000818:Animals; D001682:Biological Availability; D007213:Indomethacin / Q000008:administration & dosage / Q000032:analysis / Q000493:pharmacokinetics*; D008297:Male; D014677:Pharmaceutical Vehicles; D011817:Rabbits; D013045:Species Specificity; D013488:Suppositories; D013552:Swine; D014280:Triglycerides
chemical_list: D014677:Pharmaceutical Vehicles; D013488:Suppositories; D014280:Triglycerides; C009683:witepsol; D007213:Indomethacin